Tidal Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.68M	Buy	48,445 +33,658	+228%	+$1.96M	0.01%	1041
2025 Q4	$879K	Sell	14,787 -26,453	-64%	-$1.44M	﹤0.01%	1347
2025 Q3	$2.23M	Buy	41,240 +9,915	+32%	+$567K	0.01%	861
2025 Q2	$1.72M	Buy	31,325 +10,083	+47%	+$594K	0.01%	794
2025 Q1	$1.5M	Buy	21,242 +8,203	+63%	+$552K	0.01%	816
2024 Q4	$857K	Sell	13,039 -17,428	-57%	-$1.17M	0.01%	1088
2024 Q3	$2.14M	Buy	30,467 +18,300	+150%	+$1.53M	0.02%	613
2024 Q2	$1M	Sell	12,167 -5,280	-30%	-$440K	0.01%	896
2024 Q1	$1.52M	Buy	17,447 +6,906	+66%	+$618K	0.03%	668
2023 Q4	$1.02M	Buy	10,541 +55	+0.5%	+$4.87K	0.02%	623
2023 Q3	$928K	Buy	10,486 +568	+6%	+$50.5K	0.03%	572
2023 Q2	$860K	Buy	9,918 +3,760	+61%	+$354K	0.03%	589
2023 Q1	$599K	Buy	6,158 +388	+7%	+$40.2K	0.02%	685
2022 Q4	$597K	Buy	5,770 +719	+14%	+$67.5K	0.02%	606
2022 Q3	$428K	Buy	5,051 +284	+6%	+$25.3K	0.02%	621
2022 Q2	$395K	Sell	4,767 -25	-0.5%	-$1.99K	0.01%	678
2022 Q1	$369K	Buy	4,792 +474	+11%	+$39.7K	0.01%	766
2021 Q4	$381K	Buy	4,318 +204	+5%	+$16.8K	0.01%	694
2021 Q3	$318K	Buy	4,114 +655	+19%	+$51.7K	0.01%	666
2021 Q2	$289K	Sell	3,459 -25	-0.7%	-$1.98K	0.01%	585
2021 Q1	$263K	Buy	3,484 +1,023	+42%	+$83.6K	0.01%	465
2020 Q4	$216K	Buy	+2,461	New	+$195K	0.02%	379
2020 Q3	–	Sell	-1,653	Closed	-$204K	–	247
2020 Q2	$204K	Buy	+1,653	New	+$164K	0.03%	287